Works matching DE "CYTARABINE"
Results: 1234
Early glioma is associated with abnormal electrical events in cortical cultures.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Versatile Prodrug Strategy to In Situ Encapsulate Drugs in MOF Nanocarriers: A Case of Cytarabine‐IR820 Prodrug Encapsulated ZIF‐8 toward Chemo‐Photothermal Therapy.
- Published in:
- Advanced Functional Materials, 2018, v. 28, n. 35, p. 1, doi. 10.1002/adfm.201802830
- By:
- Publication type:
- Article
The effect of CH<sub>3</sub>, F and NO<sub>2</sub> substituents on the individual hydrogen bond energies in the adenine–thymine and guanine–cytosine base pairs.
- Published in:
- Journal of Computer-Aided Molecular Design, 2010, v. 24, n. 5, p. 409, doi. 10.1007/s10822-010-9348-2
- By:
- Publication type:
- Article
Pericarditis associated with cytarabine therapy for acute myelocytic leukemia: a case report.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 2, p. 181, doi. 10.1007/s00228-017-2355-7
- By:
- Publication type:
- Article
Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.
- Published in:
- European Journal of Clinical Pharmacology, 2015, v. 71, n. 3, p. 293, doi. 10.1007/s00228-014-1795-6
- By:
- Publication type:
- Article
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.
- Published in:
- Nature, 2014, v. 511, n. 7507, p. 90, doi. 10.1038/nature13283
- By:
- Publication type:
- Article
Landscape of genomic alterations in cervical carcinomas.
- Published in:
- Nature, 2014, v. 506, n. 7488, p. 371, doi. 10.1038/nature12881
- By:
- Publication type:
- Article
Development and Evaluation of Cellulose Derivative and Pectin Based Swellable pH Responsive Hydrogel Network for Controlled Delivery of Cytarabine.
- Published in:
- Gels (2310-2861), 2023, v. 9, n. 1, p. 60, doi. 10.3390/gels9010060
- By:
- Publication type:
- Article
Advanced Photocatalytic Degradation of Cytarabine from Pharmaceutical Wastewaters.
- Published in:
- Toxics, 2024, v. 12, n. 6, p. 405, doi. 10.3390/toxics12060405
- By:
- Publication type:
- Article
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients.
- Published in:
- 2019
- By:
- Publication type:
- Opinion
Cytarabine‐induced pericarditis confirmed using cardiac MRI: A case report.
- Published in:
- Echocardiography, 2021, v. 38, n. 8, p. 1446, doi. 10.1111/echo.15135
- By:
- Publication type:
- Article
Two‐dimensional speckle‐tracking strain detects subclinical cardiotoxicity in older patients treated for acute myeloid leukemia.
- Published in:
- Echocardiography, 2019, v. 36, n. 11, p. 2033, doi. 10.1111/echo.14518
- By:
- Publication type:
- Article
Fast and Complete Destruction of the Anti-Cancer Drug Cytarabine from Water by Electrocatalytic Oxidation Using Electro-Fenton Process.
- Published in:
- Catalysts (2073-4344), 2022, v. 12, n. 12, p. 1598, doi. 10.3390/catal12121598
- By:
- Publication type:
- Article
SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 7, p. 1, doi. 10.1002/ctm2.1311
- By:
- Publication type:
- Article
The influence of cytidine deaminase -33delC polymorphism on treatment outcome with high-dose cytarabine in Chinese patients with relapsed acute myeloid leukaemia.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 5, p. 555, doi. 10.1111/jcpt.12309
- By:
- Publication type:
- Article
Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2013, v. 38, n. 3, p. 262, doi. 10.1111/jcpt.12058
- By:
- Publication type:
- Article
Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1142449
- By:
- Publication type:
- Article
Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193874
- By:
- Publication type:
- Article
High-dose cytarabine monotherapy is superior to standard-dose cytarabine-based multiagent sequential treatment cycle for consolidation treatment in adult (14-59 years) AML patients according to European Leukemia Net 2022 risk stratification.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2022.1070588
- By:
- Publication type:
- Article
Vyxeos First Treatment Approved Specifically for 2 Types of High-Risk AML.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2017, v. 8, p. 25
- Publication type:
- Article
Time Controlled Release of Arabinofuranosylcytosine (Ara-C) from Agarose Hydrogels using Layer-by-Layer Assembly: An In Vitro Study.
- Published in:
- Journal of Biomaterials Science -- Polymer Edition, 2012, v. 23, n. 1-4, p. 439, doi. 10.1163/092050610X552221
- By:
- Publication type:
- Article
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 1, p. 150, doi. 10.1002/ijc.33202
- By:
- Publication type:
- Article
Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study.
- Published in:
- Clinical Epigenetics, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13148-020-00923-4
- By:
- Publication type:
- Article
CHK1 as a therapeutic target to bypass chemoresistance in AML.
- Published in:
- Science Signaling, 2016, v. 9, n. 445, p. 1, doi. 10.1126/scisignal.aac9704
- By:
- Publication type:
- Article
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives.
- Published in:
- BioScience Trends, 2017, v. 11, n. 1, p. 110, doi. 10.5582/bst.2016.01221
- By:
- Publication type:
- Article
Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients with Relapsed/Refractory Acute Myeloid Leukemia.
- Published in:
- Advances in Hematology, 2017, p. 1, doi. 10.1155/2017/6464972
- By:
- Publication type:
- Article
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review.
- Published in:
- Expert Review of Clinical Pharmacology, 2019, v. 12, n. 3, p. 197, doi. 10.1080/17512433.2019.1573668
- By:
- Publication type:
- Article
Azacitidine Combined with Cytarabine in Older Patients with Newly Diagnosed AML.
- Published in:
- International Journal of Gerontology, 2022, v. 16, n. 1, p. 57, doi. 10.6890/IJGE.202201_16(1).0011
- By:
- Publication type:
- Article
SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax.
- Published in:
- Neoplasma, 2022, v. 69, n. 5, p. 1108, doi. 10.4149/neo_2022_220415N416
- By:
- Publication type:
- Article
Acute myelogenous leukemia in pregnancy: fetal blood sampling and early effects of chemotherapy.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Chronic myelomonocytic leukaemia: leukaemia cutis predicts disease progression.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
An atypical isolated CNS blast crisis in chronic myeloid leukaemia.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Therapeutic options for acute myelogenous leukemia.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Assessment of pulmonary and cardiac function after high dose chemotherapy with BEAM and peripheral blood progenitor cell transplantation.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Biocompatible polymeric blend for pH driven delivery of cytarabine: Effect of feed contents on swelling and release kinetics.
- Published in:
- Journal of Biomedical Materials Research, Part B: Applied Biomaterials, 2022, v. 110, n. 7, p. 1545, doi. 10.1002/jbm.b.35016
- By:
- Publication type:
- Article
Systemic mastocytosis with associated acute myelogenous leukemia.
- Published in:
- Baylor University Medical Center Proceedings, 2014, v. 27, n. 1, p. 22, doi. 10.1080/08998280.2014.11929041
- By:
- Publication type:
- Article
Granulocytic sarcoma and HIV.
- Published in:
- Baylor University Medical Center Proceedings, 2011, v. 24, n. 4, p. 306, doi. 10.1080/08998280.2011.11928745
- By:
- Publication type:
- Article
Presumed optic neuritis of non‐infectious origin in dogs treated with immunosuppressive medication: 28 dogs (2000‐2015).
- Published in:
- Journal of Small Animal Practice, 2020, v. 61, n. 11, p. 676, doi. 10.1111/jsap.13233
- By:
- Publication type:
- Article
Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1421, doi. 10.3390/ijms25031421
- By:
- Publication type:
- Article
Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12926, doi. 10.3390/ijms241612926
- By:
- Publication type:
- Article
Inhibitors of Chemoresistance Pathways in Combination with Ara-C to Overcome Multidrug Resistance in AML. A Mini Review.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 9, p. 4955, doi. 10.3390/ijms22094955
- By:
- Publication type:
- Article